Results of clinical trials of a novel glycoprotein IIb-IIIa antagonist framon in high-risk coronary angioplasty
Autor: | Mazurov, A. V., Pevzner, D. V., Staroverov, I. I., Samko, A. N., Antonova, O. A., Ivanov, V. A., Sergey A. Abugov, Gontuar, M. G., Chestukhin, V. V., Vlasik, T. N., Ruda, M. Ya |
---|---|
Zdroj: | Scopus-Elsevier ResearcherID |
Databáze: | OpenAIRE |
Externí odkaz: |